SANDERS MACHELLE (CIK 1718020) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-05). Recent activity: Sell FTRE (9,700 shares), Buy BCRX (15,294 shares), Buy FTRE (38,817 shares), Sell BCRX (9,600 shares), Buy BCRX (12,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Fortrea Holdings Inc. (FTRE) | Director | Sell | 9,700 | $174,697 |
| 2026-06-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 15,294 | $0 |
| 2026-06-12 | Fortrea Holdings Inc. (FTRE) | Director | Buy | 38,817 | $0 |
| 2025-11-17 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Sell | 9,600 | $68,544 |
| 2025-06-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,500 | $0 |
| 2025-05-16 | Fortrea Holdings Inc. (FTRE) | Director | Buy | 7,282 | $0 |
Source: SEC Form 4 filings · as of 2026-08-05